QOP

6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide


Toggle HydrogenToggle Labels

Chemical Component Summary

Name6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide
Synonymstovorafenib
Identifiers2-[(1~{R})-1-[(6-azanyl-5-chloranyl-pyrimidin-4-yl)carbonylamino]ethyl]-~{N}-[5-chloranyl-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide
FormulaC17 H12 Cl2 F3 N7 O2 S
Molecular Weight506.289
TypeNON-POLYMER
Isomeric SMILESC[C@H](c1ncc(s1)C(=O)Nc2cc(c(cn2)Cl)C(F)(F)F)NC(=O)c3c(c(ncn3)N)Cl
InChIInChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1
InChIKeyVWMJHAFYPMOMGF-ZCFIWIBFSA-N

Chemical Details

Formal Charge0
Atom Count44
Chiral Atom Count1
Bond Count46
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB15266 
NameTovorafenib
Groups investigational
DescriptionTovorafenib (TAK-580) is under investigation in clinical trial NCT02723006 (Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma).
Synonyms
  • 6-amino-5-chloro-N-[1R)-1-[5-[[[5-hloro-4-(trifluoromethyl)-2pyridinyl]amino]carbonyl]-2-thiazoyl]ethyl]-4-pyrimdinecarboxamide
  • 6-Amino-5-chloro-N-((1R)-1-(5-(((5-chloro-4-(trifluoromethyl)-2-pyridinyl)amino)carbonyl)-2-thiazolyl)ethyl)-4-pyrimidinecarboxamide
  • Tovorafenib
  • 4-Pyrimidinecarboxamide, 6-amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Sulfur Compounds
CAS number1096708-71-2

Related Resource References

Resource NameReference
Pharos CHEMBL3348923
PubChem 25161177
ChEMBL CHEMBL3348923